Multi-nutrient supplement improves hormone ratio associated with cancer risk

被引:1
|
作者
Bazzan, Anthony J. [1 ]
Zabrecky, George P. [1 ]
Newberg, Andrew B. [1 ]
机构
[1] Thomas Jefferson Univ, Myrna Brind Ctr Integrat Med, Philadelphia, PA 19107 USA
关键词
Hormone; Nutrient; Cancer; Proliferative; Indole; Flavonoid; BREAST-CANCER; ESTROGEN METABOLITES; FLAVONOIDS; CELLS; WOMEN; PREMENOPAUSAL; PROLIFERATION; ACTIVATION; EXTRACTS;
D O I
10.1186/1479-5876-11-252
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Gynecological cancers are among the most common in women and are directly related to a variety of hormonal factors. One potential risk factor associated with developing a gynecological malignancy is the ratio of two hormone metabolites, 2-Hydroxyestrone (2-HE) and 16alpha-Hydroxyestrone (16alpha-HE). A number of botanical constituents such as indoles, flavonoids, and resveratrol have been shown to have a favorable effect on the metabolic pathways that affect this ratio. The present study was designed to evaluate if a multi-nutrient supplement containing targeted botanical constituents would affect the 2-HE/16 alpha-HE ratio in middle-aged women. Methods: A retrospective analysis was performed on 76 female patients (mean age 54 years) who received 2-HE/16 alpha-HE ratio assessments at two separate time points. The ratio assessment was part of standard care for women who presented with risk indicators associated with a high proliferative state. All patients who completed pre and post assessments were included. Sixty-five of the patients received a multi-nutrient supplement, Lucentia Peak (R), during the study period. Eleven patients chose not to take the supplement, but did receive ratio assessments at similar time points as the treatment group, allowing for between group comparisons. Paired t-tests were used to compare the changes in the 2-HE and 16alpha-HE measures as well as their ratio, both within groups and between groups. Results: The results demonstrated a significant increase in the 2-HE/16alpha-HE ratio in the treated group (pre 0.38 to post 0.57, p<0.0001), and was significantly different (p=0.02) compared to the change in the control group (pre 0.65 to post 0.64). This change appears to be mediated primarily by an increase in the 2-HE level. Individually, 54 patients given Lucentia Peak (R) had increased ratios while 11 patients had a decrease. In the control group, 3 patients had an increase in their ratio and 8 patients had a decrease. Conclusions: The results demonstrated that women receiving the Lucentia Peak (R) multi-nutrient supplement had significant increases in their 2-HE: 16alpha-HE ratio, which appears to be mediated primarily by increasing the 2-HE levels. These results suggest further research on phytonutrients that might positively affect estrogen metabolism is warranted.
引用
下载
收藏
页数:4
相关论文
共 50 条
  • [31] Cancer risk associated with exogenous hormone use in BRCA mutation carriers
    Kotsopoulos, J.
    CANCER RESEARCH, 2024, 84 (09)
  • [32] Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer
    Itaya, Tomoaki
    Sano, Makoto
    Kajiwara, Ichie
    Oshima, Yukino
    Kuramochi, Tomoya
    Kim, Jinsuk
    Ichimaru, Yoshimi
    Kitajima, Osamu
    Masamune, Atsushi
    Ijichi, Hideaki
    Ishii, Yukimoto
    Suzuki, Takahiro
    PAIN, 2023, 164 (07) : 1545 - 1554
  • [33] High neutrophil to lymphocytes ratio is associated with sarcopenia risk in hospitalized cancer patients
    Borges, Thais C.
    Gomes, Tatyanne LN.
    Pichard, Claude
    Laviano, Alessandro
    Pimentel, Gustavo D.
    CLINICAL NUTRITION, 2021, 40 (01) : 202 - 206
  • [34] Histology-specific standardized incidence ratio improves the estimation of second primary lung cancer risk
    Eberl, Marian
    Tanaka, Luana F.
    Kraywinkel, Klaus
    Klug, Stefanie J.
    BMC MEDICINE, 2024, 22 (01):
  • [35] Use of hormone replacement therapy - Evidence on risk of breast cancer associated with hormone replacement therapy is still inconclusive
    McKinney, K
    BRITISH MEDICAL JOURNAL, 1996, 313 (7058): : 686 - 686
  • [36] Skin carotenoid levels are not associated with risk of nonmelanoma skin cancer: Response to "Supplement use and the risk of cutaneous squamous cell carcinoma"
    Corey, Kristen C.
    Garshick, Marisa Kardos
    Dejsuphong, Voraphat
    Lima, Xinaida T.
    Kimball, Alexandra B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (05) : 1071 - 1072
  • [37] Hazard ratio for colorectal cancer risk in Lynch syndrome is inversely associated with age.
    Jenkins, Mark A.
    Win, Aung Ko
    Dowty, James G.
    Mathews, John D.
    Hopper, John L.
    CANCER RESEARCH, 2013, 73 (08)
  • [38] Sex hormones and genetic variants in hormone metabolic pathways associated with the risk of colorectal cancer
    Li, Shuwei
    Chen, Yehua
    Xie, Lisheng
    Meng, Yixuan
    Zhu, Lingjun
    Chu, Haiyan
    Gu, Dongying
    Zhang, Zhengdong
    Du, Mulong
    Wang, Meilin
    ENVIRONMENT INTERNATIONAL, 2020, 137
  • [39] Prediagnostic Circulating Anti-Mullerian Hormone Concentrations Are Not Associated with Prostate Cancer Risk
    Sklavos, Martha M.
    Zhou, Cindy Ke
    Pinto, Ligia A.
    Cook, Michael B.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11) : 2597 - 2602
  • [40] Colorectal Cancer Risk Associated with Hormone Use Varies by Expression of Estrogen Receptor-β
    Rudolph, Anja
    Toth, Csaba
    Hoffmeister, Michael
    Roth, Wilfried
    Herpel, Esther
    Schirmacher, Peter
    Brenner, Hermann
    Chang-Claude, Jenny
    CANCER RESEARCH, 2013, 73 (11) : 3306 - 3315